# A Phase I Trial to Assess the Effects of Food and Formulation on PK of KPT-330 in Patients With Sarcoma

> **NCT01896505** · PHASE1 · COMPLETED · sponsor: **Karyopharm Therapeutics Inc** · enrollment: 54 (actual)

## Conditions studied

- Sarcoma

## Interventions

- **DRUG:** KCP-330

## Key facts

- **NCT ID:** NCT01896505
- **Lead sponsor:** Karyopharm Therapeutics Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-07-30
- **Primary completion:** 2016-10-21
- **Final completion:** 2016-10-21
- **Target enrollment:** 54 (ACTUAL)
- **Last updated:** 2024-01-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01896505

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01896505, "A Phase I Trial to Assess the Effects of Food and Formulation on PK of KPT-330 in Patients With Sarcoma". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01896505. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*